Inter-alpha-trypsin inhibitor heavy chain 4(ITI-H4)is expressed in chondrocytes and a biomarker of O

来源 :2016年第18届亚太风湿病协会联盟大会(APLAP) | 被引量 : 0次 | 上传用户:cctasty
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Objective:The present research is to understand whether ITI-H4 be produced by synovial cells or chondrocytes,and the different expressing level of ITI-H4 in these cells between normal and OA patients.Methods:Chondrocytes and synoviocytes were separated from cartilage and synovial tissue extracted from patients with hip fracture as normal donors and from patients with knee osteoarthritis after arthroplasty.The expression level of ITI-H4 in these cells was detected by Western blot and RT-PCR.The localization of ITI-H4 was determined by immunohistochemistry.Results:ITI-H4 was expressed in a 90-kDa form in chondrocytes from both OA and normal samples,but not in synoviocytes.Secretory ITI-H4 proteins level in synovial fluids from OA patients were higher than in synovial fluid from RA measured by ELISA(P<0.05).Immunohistochemistry showed intracellular staining of ITI-H4 in both OA and normal cartilage.However,the localization of positive cells was different between OA and normal.The ITI-H4 positive cells were mostly found in the superficial region especially in fibrillated surface of OA cartilage,while in normal they were well-distributed in the each layer of the tissue.Conclusion:ITI-H4 in synovial fluid may be derived from cartilage but not synovium.ITI-H4 might be a biomarker of OA for it detected higher in synovial fluid from OA patients than in that from RA.And the function of ITI-H4 in cartilage and the part taken in OA should be further investigated.
其他文献
Objective Lung cancer is a leading cause of cancer-related death in the world.Despite major advances in combination treatments,the prognosis of non-small cell lung cancer(NSCLC)is still dismal.
Objective It is widely accepted that leukemogenesis results from the accumulation of genetic and epigenetic alteration during the multistep process of tumorigenesis; however,accumulating evidence has
Objective Hepatocellular carcinoma(HCC)is one of the leading causes of cancerrelated death world-wide,especially in China.Chemotherapy is still the main treatment of HCC since many HCC patients fail t
目的 本实验通过免疫组织化学法检测Ago2、HIF1α在EGFR突变型及野生型肺腺癌中的表达,探讨在缺氧情况下,Ago2的表达水平是否与EGFR突变相关,并结合相关临床资料,分析HIF1α 、Ago2 与EGFR 突变的联合检测对评估肺腺癌发生、发展的意义,为肺腺癌的早期诊断、治疗及预后提供新思路。
目的 RAS 突变型结直肠癌预后较差,迄今为止没有特异性针对RAS 的靶向药物。如何治疗RAS 突变型结直肠癌是亟待解决的问题。近期Cell杂志发表的论著认为:Rigosertib(RGS)是一种RAS模拟小分子,竞争性结合RAS 效应蛋白,封闭RAS 作用位点,从而阻断其下游信号通路过度活化。
会议
Objective:To observe the injury of arthrosis in patients with osteoarthritis under the arthroscope.Methods:A retrospective analysis was conducted to the clinical data including arthroscopical findings
会议
会议
会议